Oncaspar 750 UI/ml soluzione iniettabile
Country: Switzerland
Language: Italian
Source: Swissmedic (Swiss Agency for Therapeutic Products)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
pegaspargasum
Available from:
Servier (Suisse) SA
ATC code:
L01XX24
INN (International Name):
pegaspargasum
Pharmaceutical form:
soluzione iniettabile
Composition:
pegaspargasum 750 U.I., natrii dihydrogenophosphas anhydricus, dinatrii phosphas, natrii chloridum, aqua ad iniectabile q.s. ad solutionem pro 1 ml.
Class:
A
Therapeutic group:
Biotechnologika
Therapeutic area:
Oncaspar è indicato in combinazione con altri agenti antineoplastici per il trattamento della leucemia linfoblastica acuta (ALL)
Authorization date:
2017-02-21
